LVTX   $1.65  10.00% Market Closed

LAVA Therapeutics NV
Total Cash 86.80M
totalCashPerShare 3.301
EBITDA -26.88M
Total Debt 6.16M
quickRatio 6.233
currentRatio 6.39
Total Revenue 7.40M
debtToEquity 14.373
Revenue/Share 0.274
ROA -0.15991001
ROE -0.45299
grossProfits
freeCashflow -17.98M
operatingCashflow -27.08M
earningsGrowth
revenueGrowth
grossMargins 0.97783
ebitdaMargins 0.0
operatingMargins -3.71479
profitMargins 0.0
enterpriseValue -32.78M
forwardPE -0.9793814
floatShares 12.09M
sharesOutstanding 26.30M
sharesShort 2.43K
sharesShortPriorMonth 32.47K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.33%
Short Ratio help_outline 0.07%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 1.631
Price To Book help_outline 1.16
earningsQuarterlyGrowth
netIncomeToCommon -24.18M
trailingEps -0.89%
forwardEps -1.94%
enterpriseToEbitda 1.22
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.33 3Q 2024
institutionsCount 22
lastUpdated Nov. 7, 2024, 4:59 a.m.